Governance by stealth: Large-scale pharmacogenomics and biobanking in Japan

Biobanks: Governance in Comparative Perspective

Volumn , Issue , 2008, Pages 123-140

  Triendl, Robert ^a   Gottweis, Herbert ^b  

^a Translational Research Ltd   (Japan)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957605924     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203927991     Document Type: Chapter

References (38)

1. Asian Technology Information Program (2003) The Biobank Japan Project, ATIP03.042. Report available online at www.atip.org (accessed 6 October 2006; document on file with authors).
2. Branscomb, L., Kodama, F. and R. Florida (eds) (1999) Industrializing Knowledge: University-Industry Linkages in Japan and the United States. Cambridge, MA: MIT Press.
3. Coleman, S. (1998) Japanese Science: From the Inside. London: Routledge.
4. Dyer, O. (2003) 'FDA announces fast track approval of new drug for lung cancer', BMJ, 326: 1004.
5. Feldman, E. A. (2000) The Ritual of Rights in Japan: Law, Society, and Health Policy. Cambridge: Cambridge University Press.
6. Hama R. and Sakaguchi, K. (2003) 'The Gefitinib story', ISDB Newsletter, 17: 1. Available at www.npojip.org/english/The- gefitinib-story.pdf (accessed 9 October 2006).
7. Hill, D. E., Brasch, M. E., del Campo, A. A., Doucette-Stamm, L., Garrels, J. I. et al. (2004) 'Academia-industry collaboration: an integral element for building "omic" resources', Genome Research, 14: 2010-14.
8. Hiroi, Y. (1992) Amerika no iryôseisaku to nihon: kagaku, bunka, keizai no interface (US Health Policy and Japan: At the Interface Between Science, Culture, and the Economy). Tokyo: Chikuma Shôbô.
9. Hito soshiki no ishoku-to e no riyô no arikata ni kan-suru senmon iinkai (2000) Hito soshiki no ishoku-to e no riyô no arikata ni tsuiteio Hito(Guidelines for the transplantation of human tissues). Tokyo: Ministry of Health and Welfare.
10. Kneller, R. W. (2003) 'University-industry cooperation and technology transfer in Japan compared with the US: another reason for Japan's economic malaise?', University of Pennsylvania Journal of International Economic Law, 24: 329-449.
11. Kôsei kagaku shingikai sentan iryô gijutsu hyoka bukai (2000a) Ekigaku-teki shuhô o mochiiru kenkyû-tô ni okeru kojin jôhô no hogo-to no arikata ni kan-suru chôsa kenkyû (Considerations on Data and Privacy Protection in Epidemiological Research). Tokyo: Ministry of Health and Welfare.
12. Kôsei kagaku shingikai sentan iryô gijutsu hyoka bukai (2000b) Idenshi kaiseki kenkyû ni fuzui suru rinri mondai-to ni taio suru tame no shishin (Guidelines Concerning Ethical Issues Related to Human Genome Research). Tokyo: Ministry of Health and Welfare.
13. Kôsei kagaku shingikai sentan iryô gijutsu hyoka bukai (2000c) Soshiki bank jigyô o tsujite hito soshiki no ishoku-to e no riyo no arikata ni tsuite (Rules for the Transplantation of Human Tissues Using Tissue Banks). Tokyo: Ministry of Health and Welfare.
14. Kôsei kagaku shingikai sentan iryo gijutsu hyôka bukai, hito-soshiki o mochiiru kenkyû kaihatsu no arikata ni kan-suru senmon iinkai (1998) Shujutsu-to de teishutsu sareta hito-soshiki no kenkyu kaihatsu no arikata ni tsuite (Rules for the research use of human surplus tissues from surgical interventions). Tokyo: Ministry of Health and Welfare, Health Policy Bureau.
15. Kôsei-shô (2000). Idenshi kaiseki ni yoru shippei taisaku zoyaku ni kan-suru kenkyu ni okeru seimei rinri mondai ni kan-suru chosa kenkyu (Research on Bioethics Issues in Human Genome Research). Tokyo: Ministry of Health and Welfare.
16. Leflar, R. (1996) 'Informed consent and patients' rights in Japan', Houston Law Review, 33: 1-112.
17. Macer, D. (1992) 'The "far east" of biological ethics', Nature, 359: 770.
18. Mandavilli, A. (2004) 'Profile Yusuke Nakamura', Nature Medicine, 10: 560.
19. Maruyama, E. (2000) 'Hito genomu kenkyû, idenshi kaiseki ni kan-suru saikin no seifu shishin' ('On Recent Guidelines for Genetics and Genomics Research'), Jurisuto, 1193: 49-55.
20. Masui, T. (2002) 'Hito no koto ha hito deiu jidai no naka de: jintai-yûrai shiryô ni izon shita iryô seibutsu-gaku kenkyû no kiban-seibi nit suite' [original English language title: 'On the required infrastructure of the current use of human materials and information in biomedical research in Japan'], Rinshô Hyôka, 30.
21. Masui, T., Sofuni, T., Ishü, M., Imanishi, Y., Hideaki et al. (2000) 'Kôsei saibô banku ni okeru hito soshiki, saibô toriatsukai rinri mondai e no torikumi' ('Approach toward ethical issues regarding human cell and tissue use at the JCRB Cell Bank'), Tissue Culture Research Communications, 19: 1-15.
22. Morioka Todeschini, M. (1995) Hiroshima 50 ans. Paris: Autrement.
23. Morioka Todeschini, M. (1999) 'Illegitimate sufferers: A-bomb victims, medical science, and the government', Daedalus, 128: 67-100.
24. Muto, K. et al. (2000) 'Nihon no idenbyô kenkyuu to kanja, kazoku no kea ni kansuru chôsa' ['Research on genetic diseases and patient and family care in Japan: a survey'], Studies, 4.
25. Nakamura, Y. (2003) Interview with authors, Institute for Medical Sciences, University of Tokyo, 6 October.
26. Normile, D. (2003) 'Japan guidelines under fire after protest halts study', Science, 301: 1039.
27. Nudeshima, J. (2001) Sentan iryô no rûru: jintai riyô wa doko made yurusarerunoka (Rules for Advanced Medicine: To what Extent Should the Use of the Human Body Be allowed?). Tokyo: Kôdan-sha.
28. Paez, J. G. (2004) 'EGFR mutations in lung cancer: correlation with clinical response to Gefitinib therapy', Science, 304: 1497-1500.
29. Pechter, K. (2001) 'Measuring the University-Industry Linkage in Japan: System Assessment for Innovation', unpublished doctoral dissertation, University of Tokyo.
30. Porter, G. (2004) 'The Regulation of Human Genetic Databases in Japan', SCRIPT-ed, 1: 491. Available online at www.law.ed.ac.uk/ahrb/script- ed/issue3/japan.asp (accessed 6 October 2006; document on file with authors).
31. Rabinow, P. and Dan-Cohen, T. (2005) A Machine to Make a Future: Biotech Chronicles. Princeton, NJ: Princeton University Press.
32. Riken Advisory Council (2004) Strengthening Scientific Governance in an Age of Change, Report by the 5th RAC. Wako: RIKEN, The Institute for Physical and Chemical Research. See also www.riken.jp/engn/r-world/info/report/rac/index.html (accessed 12 December 2006; report on file with authors).
33. Salter, A. J. and Martin, B. R. (2001) 'The economic benefits of publicly funded basic research: a critical review', Research Policy, 30: 509-32.
34. Schwartz, F. J. and Pharr, S. J. (eds) (2003) The State of Civil Society in Japan. Cambridge: Cambridge University Press.
35. Triendl, R. (1999a) 'Japan reorganizes national biomedical research groups', Nature Medicine, 5: 365.
36. Triendl, R. (1999b) 'Millennium money for Japanese scientists', Nature Medicine, 5: 1095.
37. Tsuboi, E., Kawahara, N., Mitsuishi, T., Oshima, A. and Yonemoto, S. (2002) 'Data security is crucial for Japanese science', Nature, 417: 689.
38. Upham, F. K. (1996) 'Privatized regulation: Japanese regulatory style in comparative and international perspective', Fordham International Law Journal, 20: 396-511.